Fear of Cancer Recurrence in Genitourinary Cancer

Sponsor
Ludwig-Maximilians - University of Munich (Other)
Overall Status
Recruiting
CT.gov ID
NCT04535921
Collaborator
(none)
500
1
32.9
15.2

Study Details

Study Description

Brief Summary

To perform an analysis of independent predictors of fear of cancer recurrence in patients with malignant genitourinary diseases and their impact on quality of life and survival

Condition or Disease Intervention/Treatment Phase
  • Other: FCR7 questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Fear of Cancer Recurrence in Malignant Diseases of the Genitourinary Tract
Actual Study Start Date :
Nov 5, 2019
Actual Primary Completion Date :
Apr 30, 2021
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Prostatectomy

FCR7 questionnaire pre and postoperative

Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence

Cystectomy

FCR7 questionnaire pre and postoperative, 6 months follow

Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence

Nephrectomy

FCR7 questionnaire pre and postoperative

Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence

Orchidectomy

FCR7 questionnaire pre and postoperative

Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence

Outcome Measures

Primary Outcome Measures

  1. Changes in fear of cancer recurrence pre- and postoperatively [7 to 10 days after initial surgery]

    Changes in the FCR7 score pre- and postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • histologically confirmed diagnosis of either prostate, urothelial cell, testicular or renal cell cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ludwig-Maximilian-Universität Munich Bavaria Germany 80796

Sponsors and Collaborators

  • Ludwig-Maximilians - University of Munich

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yannic Volz, Assistant doctor, Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT04535921
Other Study ID Numbers:
  • FCR2020
First Posted:
Sep 2, 2020
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022